tirzepatide off label is a novel medication that the FDA has approved for treating type 2 diabetes mellitus. Due to its potent weight loss properties, Tirzepatide can be used off-label for treating obesity. The FDA approves new version of

Through molecular docking and machine learning model screening, new molecules with promising anticancer properties have been identified from natural compounds and validated for activity in cellular and animal models (258)

Frequently Asked Questions How often was headache reported in the trial data this article summarizes

Efficacy of oral versus intravenous N-acetyl-cysteine in acetaminophen overdose: results of an open-label, clinical trial

It effectively regulates blood sugar levels by imitating the GLP-1 hormone, a naturally occurring hormone in the body

Wegovy (semaglutide) a once-weekly GLP-1 injection FDA-approved for chronic weight management and cardiovascular risk reduction in adults with obesity or overweight with weight-related conditions

Fertility clinics report patients conceiving naturally after years of failed treatments, with the only change being GLP-1 medication and the resulting weight loss